Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$2.8M
1 round on record
Latest round
$2.8M
Venture round · May 2025 · 16 mo ago
Team
201-500
employees, estimated range
Backers
1
OCA Ventures
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 8 Partnership OrisDX and Teledentistry.com Announce Strategic Partnership to Expand Access to Early Oral Cancer Detection · tennessean.com May 23, 2025 Raised a round Venture round $2.8M · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2025 $2.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity OrisDx Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Harald SteltzerExecutive Officer, DirectorSEC Form D
Patrick ConniffExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan.
Phenomix SciencesVenture round $2.5M · 9 mo ago • Founded 2017 • 11-50 employees
Phenomix Sciences uses AI for precision obesity medicine integrating genetic, clinical, and biomarker data. Deliver the right intervention…
TECHNOLOGY M20 Seq Single-Cell Transcriptome M20 Spatial Spatial Transcriptome PRODUCTS Single-Cell Transcriptome for FFPE Samples…
Volta LabsVenture round $12.7M · 2 yr ago • Founded 2018 • 51-200 employees • 2 roles
Volta Labs is a genomics applications company that has developed a cutting-edge sample prep system to improve performance, scalability, and…
The next generation of genome-wide on- and off-target analysis in your own hands. Our INDUCE-seq platform provides precise off-target…
PathoQuest51-200 employees
PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for…

Overview

Detect Early, Live Fully. Our mission at OrisDX is to leverage salivary rinse samples to detect disease early and guide people to early clinical intervention through the use of next-generation testing modalities backed by cutting-edge research.

People

Harald Steltzer
Executive Officer, Director
Patrick Conniff
Executive Officer
Evgeny Izmchenko
Director
Nishant Agrawal
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chicago United States
HQ
200-500 est. staff

Financials

Total raised
$2.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $2.8M Details